Skip to main content
Vaishali Pharma Limited logo

Vaishali Pharma Limited — Investor Relations & Filings

Ticker · VAISHALI ISIN · INE972X01022 LEI · 335800LHHVE3JLLKP681 National Stock Exchange of India Wholesale and retail trade
Filings indexed 428 across all filing types
Latest filing 2022-06-30 Regulatory Filings
Country IN India
Listing National Stock Exchange of India VAISHALI

About Vaishali Pharma Limited

https://www.vaishalipharma.com/

Vaishali Pharma Limited specializes in the sourcing, marketing, and distribution of a comprehensive range of healthcare products. The company’s portfolio encompasses Active Pharmaceutical Ingredients (APIs), finished formulations in various dosage forms such as tablets and injectables, and surgical supplies. It also provides veterinary products, herbal supplements, and nutraceuticals. The business model focuses on integrated supply chain management, facilitating the movement of medical products from manufacturing units to global markets. By adhering to international quality standards and leveraging an extensive distribution network, the company serves diverse therapeutic requirements. Its operations emphasize reliability in procurement and the delivery of cost-effective healthcare solutions to a global clientele across multiple regions, including Africa, Asia, and Latin America.

Recent filings

Filing Released Lang Actions
Closure of trading window
Regulatory Filings
2022-06-30 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 95% confidence The document contains detailed information about share transactions, including dates, number of shares acquired or disposed, percentage of total equity share capital, and names of promoters or persons in the promoter group. It specifically mentions acquisition and disposal of shares and references regulation 29(1), which typically relates to disclosures of shareholding changes. The document length is short (1093 characters) and focuses solely on shareholding changes rather than financial results or management commentary. Therefore, this document fits the definition of a Major Shareholding Notification (MRQ), which involves notification of changes in significant share ownership levels.
2022-06-18 English
Related Party Transaction
Regulatory Filings
2022-06-07 English
Newspaper Advertisements
Regulatory Filings Classification · 90% confidence The document text contains only references to omitted pictures and no textual content or financial data. The document length is very short (498 characters) and does not contain any report, announcement, or detailed information. It does not meet criteria for any specific report or announcement category. Given the lack of content and the fallback rule, the document is best classified as a Regulatory Filing (RNS).
2022-05-31 English
Financial Result Updates
Regulatory Filings
2022-05-30 English
Outcome of Board Meeting
Regulatory Filings
2022-05-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.